ILK and breast cancer: We coupled this with an investigation into the pattern of ILK and integrin expression changes in PMC42-ET human breast cancer cells induced by epidermal growth factor (EGF) treatment to undergo an EMT in vitro, and assessed whether these integrin changes were necessary for EMT to occur.